Should go into the OMAHA2a ODM-208 (M... - Advanced Prostate...

Advanced Prostate Cancer

21,056 members26,262 posts

Should go into the OMAHA2a ODM-208 (MK-5684-004): phase 3 trial?

LakeT profile image
3 Replies

I had my 3 monthly OC visit last week. Blood test is showing 0.3 up from 0.15 six weeks ago. MO is suggesting that I should go into the ODM-208 (MK-5684): phase 3 trial if PSA rises above 1.0. PSA of 1.0 or above is a entry requirement for the trial, presumable to be sure that my current treatment has failed. The arms of the trial are:

1:Hormone replacement therapy (HRT)+ opevesostat

Participants receive opevesostat 5 mg by oral tablets twice daily (BID) plus dexamethasone 1.5 mg by oral tablets and fludrocortisone acetate 0.1 mg oral tablet once daily (QD) continuously until disease progression. Hydrocortisone 100 mg (oral or intramuscular [IM]) will also be provided to participants for use as rescue medication.

2: Active Comparator: Alternative next generation hormonal agent (NHA)

Participants receive Abiraterone 1000 mg QD by oral tablets plus Prednisone 5 mg BID by oral tablets or Enzalutamide 160 mg QD by oral tablets until disease progression.

The comparator is basically the same as my current treatment with the option of changing from Abiraterone to Enzalutamide.

I’m not sure of my next best move. Financially a trial makes sense and opevesostat seems to have good results so far albeit it seems to be only tested with patients with an androgen receptor gene ligand-binding domain mutation (ARmut, AR LBD). There is only a 50% chance of receiving this drug in the trial and the active comparator feels like I may miss out on current standard of care, whatever that may be and whatever that may cost.

Any advice would be appreciated please.

Written by
LakeT profile image
LakeT
To view profiles and participate in discussions please or .
Read more about...
3 Replies
God_Loves_Me profile image
God_Loves_Me

You already have docetaxal in 2022, Have you tried enzalutamide, or apalutamide or darolutamide ?

LakeT profile image
LakeT in reply to God_Loves_Me

Only Abiraterone so far and nothing else suggested yet. I'll research these three for my next discussion. Enzalutamide is an active comparator in the study. Thanks.

j-o-h-n profile image
j-o-h-n in reply to LakeT

Here's hoping for good results........ down under the down under...........

Good Luck, Good Health and Good Humor.

j-o-h-n

You may also like...

DES is As Effective As Lupron in Phase 3 Clinical Trial

Embark Phase 3 clinical trial

cer-treatment-a-new-standard-of-care-for-rising-psa-202312203001

Another promising androgen blocker in clinical trials: Darolutamide (ODM-201)

in phase III clinical trials. It's showing quite a bit of promise so far. It may prove to be more...

copper chelation is not something from the past: phase 2 trial gives hope!

the last participants in cohort 3 only completed dosing in January 2024, 60% of participants across...

Ups and downs of screening for a Phase 1 trial

active. If he gets on a trial, all medication will have to be cleared with the trial team. Quite a...